You are here: Home / About the Faculty / Faculty Staff

Dr Lisa Pont

Lecturer (Rural and Indigenous), Discipline of Pharmacy Practice

Qualifications

BSc BPharm PhD

Contact Details

University of Sydney
Faculty of Pharmacy
Room S243, Building A15
University of Sydney, NSW 2006
Email:
Phone +61-2-9036 9015
Fax: +61-2-9351 4391

Research Interests

Dr Pont’s research interest is the development of resources to assist the primary care pharmacist in aboriginal communities, whether remote of on the fringes of rural towns and cities.

Dr Pont has assembled a team to support self-management by Aboriginal and Torres Strait Islander peoples with chronic heart failure.

CHF is among the top four most prevalent cardiovascular conditions in the Aboriginal and Torres Strait Islander population, with an estimated prevalence ratio of 1.7 (age standardised) compared with non-Indigenous Australians.

Opportunities for Aboriginal and Torres Strait Islander peoples to make informed choices about treatment are limited. Miscommunication between health staff and patients from Aboriginal and Torres Strait Islander groups has been identified as a barrier in making informed decisions about treatment options and adherence to medical advice.

This project aims to improve patient access to heart failure information to support self-management by developing culturally and clinically appropriate resource/s. Resource development and dissemination into practice will be guided by the findings of a needs analysis at the outset of the project. The final resource/s developed may include a suite of information formats to address the identified needs and incorporate factors such as literacy levels, cultural identity, language requirements and comprehension of medical concepts.

Select Journal Articles

  1. Pont LG, van der Molen T, Denig P, van der Werf GT, Haaijer-Ruskamp FM (2004). Relationship between guideline treatment and health-related quality of life in asthma. Eur Respir J, 23(5), pp 718-22.
  2. Pont LG, van der Werf GT, Denig P, Haaijer-Ruskamp FM (2002).Identifying general practice patients diagnosed with asthma and their exacerbation episodes from prescribing data. Eur J Clin Pharmacol, 57(11), pp 819-25.
  3. Pont LG, van der Molen T, Denig P, van der Veen WJ, Haaijer-Ruskamp FM (2004). Validity of quality indicators for assessing asthma prescribing. Eur J Clin Pharmacology, 59(11), pp 833-40
  4. Pont LG, van Gilst W, Lok DJA, Kragten JA, Haaijer-Ruskamp FM (2003). The relevance of heart failure severity for treatment with evidence-based pharmacotherapy in general practice. Eur J Heart Fail, 5(2), pp 187-93
  5. Pont LG, Sturkenboom MCJM, van Gilst WH, Haaijer-Ruskamp FM (2003). Trends in prescribing for heart failure in Dutch General Practice from 1996 to 2000: Does prescribing reflect the current scientific evidence? Pharmacoepidemiology and Drug Safety, 12(4), pp 327-34
  6. Veninga CCM, Denig P, Pont LG, Haaijer-Ruskamp FM (2001). Comparison of indicators assessing the quality of drug prescribing for asthma. Health Services Research, 36(1), pp 143-61
  7. van Dijk KN, Pont LG, Franken M, de Vries CS, Brouwers JRBJ, de Jong-van den Berg LTW (2003). Use of prescribing indicators to evaluate drug use in nursing homes: A pilot study. Ann Pharmacother, 37(7-8), pp 1136-41